Poppy (B)

Thomas R. Eisenmann; Scott Duke Kominers; Jeff  Huizinga; Allison  Ciechanover

Case | HBS Case Collection | March 2020

Poppy (B)

by Thomas R. Eisenmann, Scott Duke Kominers, Jeff Huizinga and Allison Ciechanover

Abstract

Avni Patel Thompson, founder and CEO of Poppy, an online marketplace for on-demand childcare, revisits the venture's final months, and discusses the steps she took in the wake of the shutdown. This case explores experiments the company conducted to refine its original business model, as well as how Patel Thompson rekindled her entrepreneurial ambitions. It is part two of an A and B case, the A case being: Poppy: A Modern Village for Childcare Case 818 075, November 2017.

Keywords: Entrepreneurship; Marketplace Matching; Business Model; Business Exit or Shutdown; Personal Development and Career; United States;

Language: English

Format: Print

10 pages

Educators Purchase

Citation:

Eisenmann, Thomas R., Scott Duke Kominers, Jeff Huizinga, and Allison Ciechanover. "Poppy (B)." Harvard Business School Case 820-715, March 2020.

Working Paper | HBS Working Paper Series | 2020

Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design

Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver

COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order to increase CCP supply, we introduce a mechanism that utilizes two incentive schemes, respectively based on principles of “paying it backward" and “paying it forward." Under the first scheme, CCP donors obtain treatment vouchers that can be transferred to patients of their choosing. Under the latter scheme, patients obtain priority for CCP therapy in exchange for a future pledge to donate CCP if possible. We show that in steady-state, both principles generally increase overall treatment rates for all patients—not just those who are voucher-prioritized or pledged to donate. Our results also hold under certain conditions if a fraction of CCP is reserved for patients who participate in clinical trials. Finally, we examine the implications of pooling blood types on the efficiency and equity of CCP distribution.

Keywords: COVID-19; convalescent plasma; vouchers; Health Pandemics; Health Care and Treatment; Resource Allocation; Market Design;

Citation:

Kominers, Scott Duke, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver. "Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design." Harvard Business School Working Paper, No. 20-116, May 2020. (NBER Working Paper Series, No. 27143, May 2020.) View Details

Cite View Details Read Now

Faculty & Research

Poppy (B)

Abstract

Citation:

About the Authors

More from these Authors